Advertisement
Full Length Article| Volume 164, P24-31, April 2018

Progranulin facilitates the increase of platelet count in immune thrombocytopenia

Published:February 17, 2018DOI:https://doi.org/10.1016/j.thromres.2018.02.137

      Highlights

      • PGRN was preferentially expressed in plasma of ITP patients over healthy controls.
      • PGRN facilitates the increase of platelet count in ITP murine models.
      • PGRN may exert effects in ITP by promoting Treg proliferation.

      Abstract

      Introduction

      Progranulin (PGRN) is emerging as a critical immune mediator involved in a variety of autoimmune disorders. However, its role in immune thrombocytopenia (ITP) remains unclear.

      Materials and methods

      In this study, the enzyme-linked immunosorbent assay was used for determining the plasma levels of PGRN in ITP patients vs. healthy controls. In addition, the role of PGRN in ITP was investigated in two kinds of ITP murine models. Further, we explored whether PGRN functioned by affecting the number of T regulatory cells (Tregs) using flow cytometry.

      Results

      We first observed that plasma levels of PGRN were significantly elevated in ITP patients (n = 52) compared to healthy controls (n = 40), and the levels of PGRN declined in patients after receiving treatment. Additionally, we found a negative correlation between plasma PGRN levels and platelet count of ITP patients, suggesting that PGRN is involved in the pathogenesis of ITP. PGRN deficiency further decreased platelet count in a passive-transfer ITP murine model. By contrast, administration of recombinant PGRN increased platelet count in SCID mice with chronic ITP. Meanwhile, PGRN deficiency impaired proliferation of Tregs in the passive transfer ITP murine model. These data suggest that PGRN may exert a protective role in ITP by promoting Treg proliferation.

      Conclusion

      Our study revealed a new regulator involved in the pathogenesis of ITP and provided a potential strategy for management of ITP.

      Abbreviations:

      CTLs (CD8+ T lymphocytes), ELISA (enzyme-linked immunosorbent assay), ITP (immune thrombocytopenia), IBD (inflammatory bowel disease), OA (osteoarthritis), PGRN (progranulin), rPGRN (recombinant progranulin), RA (rheumatoid arthritis), SLE (systemic lupus erythematous), Th (T helper cells), Tregs (T regulatory cells), TNFα (tumor necrosis factor-α), TNFRs (tumor necrosis factor-α receptors), SCID (severe combined immunodeficiency), SEM (standard error of mean), PBMCs (peripheral blood mononuclear cells), TGFβ1 (transforming growth factor-β1)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stasi R.
        • Evangelista M.L.
        • Stipa E.
        • Buccisano F.
        • Venditti A.
        • Amadori S.
        Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
        Thromb. Haemost. 2008; 99: 4-13
        • Feng Q.
        • Xu M.
        • Yu Y.Y.
        • Hou Y.
        • Mi X.
        • Sun Y.X.
        • Ma S.
        • Zuo X.Y.
        • Shao L.L.
        • Hou M.
        • Zhang X.H.
        • Peng J.
        High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.
        J. Thromb. Haemost. 2017; 15: 1845-1858
        • Ji X.
        • Zhang L.
        • Peng J.
        • Hou M.
        T cell immune abnormalities in immune thrombocytopenia.
        J. Hematol. Oncol. 2014; 7: 72
        • Brighton T.A.
        • Evans S.
        • Castaldi P.A.
        • Chesterman C.N.
        • Chong B.H.
        Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias.
        Blood. 1996; 88: 194-201
        • Ogawara H.
        • Handa H.
        • Morita K.
        • Hayakawa M.
        • Kojima J.
        • Amagai H.
        • Tsumita Y.
        • Kaneko Y.
        • Tsukamoto N.
        • Nojima Y.
        • Murakami H.
        High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura.
        Eur. J. Haematol. 2003; 71: 283-288
        • Wang T.
        • Zhao H.
        • Ren H.
        • Guo J.
        • Xu M.
        • Yang R.
        • Han Z.C.
        Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura.
        Haematologica. 2005; 90: 914-923
        • Shan N.N.
        • Ji X.B.
        • Wang X.
        • Li Y.
        • Liu X.
        • Zhu X.J.
        • Hou M.
        In vitro recovery of Th1/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa/Fc.
        Thromb. Res. 2011; 128: e119-124
        • Zhang X.L.
        • Peng J.
        • Sun J.Z.
        • Liu J.J.
        • Guo C.S.
        • Wang Z.G.
        • Yu Y.
        • Shi Y.
        • Qin P.
        • Li S.G.
        • Zhang L.N.
        • Hou M.
        De novo induction of platelet-specific CD4(+)CD25(+) regulatory T cells from CD4(+)CD25(−) cells in patients with idiopathic thrombocytopenic purpura.
        Blood. 2009; 113: 2568-2577
        • Aslam R.
        • Hu Y.
        • Gebremeskel S.
        • Segel G.B.
        • Speck E.R.
        • Guo L.
        • Kim M.
        • Ni H.
        • Freedman J.
        • Semple J.W.
        Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia.
        Blood. 2012; 120: 2127-2132
        • Yu J.
        • Heck S.
        • Patel V.
        • Levan J.
        • Yu Y.
        • Bussel J.B.
        • Yazdanbakhsh K.
        Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura.
        Blood. 2008; 112: 1325-1328
        • Sakakura M.
        • Wada H.
        • Tawara I.
        • Nobori T.
        • Sugiyama T.
        • Sagawa N.
        • Shiku H.
        Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
        Thromb. Res. 2007; 120: 187-193
        • Olsson B.
        • Andersson P.O.
        • Jernas M.
        • Jacobsson S.
        • Carlsson B.
        • Carlsson L.M.
        • Wadenvik H.
        T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.
        Nat. Med. 2003; 9: 1123-1124
        • Zhang F.
        • Chu X.
        • Wang L.
        • Zhu Y.
        • Li L.
        • Ma D.
        • Peng J.
        • Hou M.
        Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
        Eur. J. Haematol. 2006; 76: 427-431
        • Zhao C.
        • Li X.
        • Zhang F.
        • Wang L.
        • Peng J.
        • Hou M.
        Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies.
        Haematologica. 2008; 93: 1428-1430
        • Semple J.W.
        • Freedman J.
        Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia.
        Blood. 1991; 78: 2619-2625
        • Jian J.
        • Li G.
        • Hettinghouse A.
        • Liu C.
        Progranulin: a key player in autoimmune diseases.
        Cytokine. 2018; 101: 48-55
        • Jian J.
        • Konopka J.
        • Liu C.
        Insights into the role of progranulin in immunity, infection, and inflammation.
        J. Leukoc. Biol. 2013; 93: 199-208
        • Elkabets M.
        • Gifford A.M.
        • Scheel C.
        • Nilsson B.
        • Reinhardt F.
        • Bray M.A.
        • Carpenter A.E.
        • Jirstrom K.
        • Magnusson K.
        • Ebert B.L.
        • Ponten F.
        • Weinberg R.A.
        • McAllister S.S.
        Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.
        J. Clin. Invest. 2011; 121: 784-799
        • He Z.
        • Bateman A.
        Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo.
        Cancer Res. 1999; 59: 3222-3229
        • Daniel R.
        • He Z.
        • Carmichael K.P.
        • Halper J.
        • Bateman A.
        Cellular localization of gene expression for progranulin.
        J. Histochem. Cytochem. 2000; 48: 999-1009
        • Liu C.J.
        • Bosch X.
        Progranulin: a growth factor, a novel TNFR ligand and a drug target.
        Pharmacol. Ther. 2012; 133: 124-132
        • Nykjaer A.
        • Lee R.
        • Teng K.K.
        • Jansen P.
        • Madsen P.
        • Nielsen M.S.
        • Jacobsen C.
        • Kliemannel M.
        • Schwarz E.
        • Willnow T.E.
        • Hempstead B.L.
        • Petersen C.M.
        Sortilin is essential for proNGF-induced neuronal cell death.
        Nature. 2004; 427: 843-848
        • Van Damme P.
        • Van Hoecke A.
        • Lambrechts D.
        • Vanacker P.
        • Bogaert E.
        • van Swieten J.
        • Carmeliet P.
        • Van Den Bosch L.
        • Robberecht W.
        Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival.
        J. Cell Biol. 2008; 181: 37-41
        • Yin F.
        • Banerjee R.
        • Thomas B.
        • Zhou P.
        • Qian L.
        • Jia T.
        • Ma X.
        • Ma Y.
        • Iadecola C.
        • Beal M.F.
        • Nathan C.
        • Ding A.
        Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.
        J. Exp. Med. 2010; 207: 117-128
        • Pizarro G.O.
        • Zhou X.C.
        • Koch A.
        • Gharib M.
        • Raval S.
        • Bible K.
        • Jones M.B.
        Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse.
        Int. J. Cancer. 2007; 120: 2339-2343
        • Yang D.
        • Wang L.L.
        • Dong T.T.
        • Shen Y.H.
        • Guo X.S.
        • Liu C.Y.
        • Liu J.
        • Zhang P.
        • Li J.
        • Sun Y.P.
        Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways.
        Am. J. Cancer Res. 2015; 5: 3085-3097
        • Lu Y.
        • Zheng L.
        • Zhang W.
        • Feng T.
        • Liu J.
        • Wang X.
        • Yu Y.
        • Qi M.
        • Zhao W.
        • Yu X.
        • Tang W.
        Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro.
        Gynecol. Oncol. 2014; 134: 364-371
        • Zhu J.
        • Nathan C.
        • Jin W.
        • Sim D.
        • Ashcroft G.S.
        • Wahl S.M.
        • Lacomis L.
        • Erdjument-Bromage H.
        • Tempst P.
        • Wright C.D.
        • Ding A.
        Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair.
        Cell. 2002; 111: 867-878
        • He Z.
        • Ong C.H.
        • Halper J.
        • Bateman A.
        Progranulin is a mediator of the wound response.
        Nat. Med. 2003; 9: 225-229
        • Tang W.
        • Lu Y.
        • Tian Q.Y.
        • Zhang Y.
        • Guo F.J.
        • Liu G.Y.
        • Syed N.M.
        • Lai Y.
        • Lin E.A.
        • Kong L.
        • Su J.
        • Yin F.
        • Ding A.H.
        • Zanin-Zhorov A.
        • Dustin M.L.
        • Tao J.
        • et al.
        The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.
        Science. 2011; 332: 478-484
        • Chen J.
        • Li S.
        • Shi J.
        • Zhang L.
        • Li J.
        • Chen S.
        • Wu C.
        • Shen B.
        Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity.
        Rheumatol. Int. 2016; 36: 359-364
        • Zhao Y.P.
        • Liu B.
        • Tian Q.Y.
        • Wei J.L.
        • Richbourgh B.
        • Liu C.J.
        Progranulin protects against osteoarthritis through interacting with TNF-alpha and beta-Catenin signalling.
        Ann. Rheum. Dis. 2015; 74: 2244-2253
        • Wei F.
        • Zhang Y.
        • Jian J.
        • Mundra J.J.
        • Tian Q.
        • Lin J.
        • Lafaille J.J.
        • Tang W.
        • Zhao W.
        • Yu X.
        • Liu C.J.
        PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner.
        Sci. Rep. 2014; 4: 7023
        • Tanaka A.
        • Tsukamoto H.
        • Mitoma H.
        • Kiyohara C.
        • Ueda N.
        • Ayano M.
        • Ohta S.
        • Inoue Y.
        • Arinobu Y.
        • Niiro H.
        • Horiuchi T.
        • Akashi K.
        Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.
        Arthritis Res. Ther. 2012; 14: R244
        • Qiu F.
        • Song L.
        • Ding F.
        • Liu H.
        • Shu Q.
        • Yang N.
        • Liu W.
        • Li X.
        Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus.
        Diagn. Pathol. 2013; 8: 88
        • Rodeghiero F.
        • Stasi R.
        • Gernsheimer T.
        • Michel M.
        • Provan D.
        • Arnold D.M.
        • Bussel J.B.
        • Cines D.B.
        • Chong B.H.
        • Cooper N.
        • Godeau B.
        • Lechner K.
        • Mazzucconi M.G.
        • McMillan R.
        • Sanz M.A.
        • Imbach P.
        • et al.
        Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
        Blood. 2009; 113: 2386-2393
        • Neschadim A.
        • Branch D.R.
        Mouse models for immune-mediated platelet destruction or immune thrombocytopenia (ITP).
        Curr. Protoc. Immunol. 2016; 113: 15.30.1-15.30.13
        • Neschadim A.
        • Branch D.R.
        Mouse models of autoimmune diseases: immune thrombocytopenia.
        Curr. Pharm. Des. 2015; 21: 2487-2497
        • Chow L.
        • Aslam R.
        • Speck E.R.
        • Kim M.
        • Cridland N.
        • Webster M.L.
        • Chen P.
        • Sahib K.
        • Ni H.
        • Lazarus A.H.
        • Garvey M.B.
        • Freedman J.
        • Semple J.W.
        A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.
        Blood. 2010; 115: 1247-1253
        • Hou Y.
        • Feng Q.
        • Xu M.
        • Li G.S.
        • Liu X.N.
        • Sheng Z.
        • Zhou H.
        • Ma J.
        • Wei Y.
        • Sun Y.X.
        • Yu Y.Y.
        • Qiu J.H.
        • Shao L.L.
        • Liu X.G.
        • Hou M.
        • Peng J.
        High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.
        Blood. 2016; 127: 1587-1597
        • Thrombosis and Hemostasis group, Hematology Society, Chinese Medical Association
        Consensus of Chinese experts on diagnosis and treatment of adult primary immune thrombocytopenia (version 2012).
        Zhonghua Xue Ye Xue Za Zhi. 2012 Nov; 33: 975-977
        • Ma D.
        • Zhu X.
        • Zhao P.
        • Zhao C.
        • Li X.
        • Zhu Y.
        • Li L.
        • Sun J.
        • Peng J.
        • Ji C.
        • Hou M.
        Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura.
        Ann. Hematol. 2008; 87: 899-904
        • Panitsas F.P.
        • Mouzaki A.
        Effect of splenectomy on type-1/type-2 cytokine gene expression in a patient with adult idiopathic thrombocytopenic purpura (ITP).
        BMC Blood Disord. 2004; 4: 4
        • Ma L.
        • Liang Y.
        • Fang M.
        • Guan Y.
        • Si Y.
        • Jiang F.
        • Wang F.
        The cytokines (IFN-gamma, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-beta1) levels in adults with immune thrombocytopenia.
        Pharmazie. 2014; 69: 694-697
        • Andersson P.O.
        • Olsson A.
        • Wadenvik H.
        Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura.
        Br. J. Haematol. 2002; 116: 862-867
        • Fahim N.M.
        • Monir E.
        Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
        Egypt. J. Immunol. 2006; 13: 173-187
        • Arandi N.
        • Mirshafiey A.
        • Jeddi-Tehrani M.
        • Shaghaghi M.
        • Sadeghi B.
        • Abolhassani H.
        • Sharifian R.A.
        • Rahiminejad M.S.
        • Aghamohammadi A.
        Alteration in frequency and function of CD4+CD25+FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura.
        Iran. J. Allergy Asthma Immunol. 2014; 13: 85-92
        • Wei F.
        • Zhang Y.
        • Zhao W.
        • Yu X.
        • Liu C.J.
        Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions.
        PLoS One. 2014; 9e112110
        • Kwack K.H.
        • Lee H.W.
        Progranulin inhibits human T lymphocyte proliferation by inducing the formation of regulatory T lymphocytes.
        Mediat. Inflamm. 2017; 2017: 7682083
        • Xing Q.
        • Su H.
        • Cui J.
        • Wang B.
        Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
        Immunol. Investig. 2012; 41: 15-27
        • Psaila B.
        • Bussel J.B.
        Refractory immune thrombocytopenic purpura: current strategies for investigation and management.
        Br. J. Haematol. 2008; 143: 16-26
        • Zhou M.
        • Tang W.
        • Fu Y.
        • Xu X.
        • Wang Z.
        • Lu Y.
        • Liu F.
        • Yang X.
        • Wei X.
        • Zhang Y.
        • Liu J.
        • Geng X.
        • Zhang C.
        • Wan Q.
        • Li N.
        • Yi F.
        Progranulin protects against renal ischemia/reperfusion injury in mice.
        Kidney Int. 2015; 87: 918-929
        • Xu X.
        • Gou L.
        • Zhou M.
        • Yang F.
        • Zhao Y.
        • Feng T.
        • Shi P.
        • Ghavamian A.
        • Zhao W.
        • Yu Y.
        • Lu Y.
        • Yi F.
        • Liu G.
        • Tang W.
        Progranulin protects against endotoxin-induced acute kidney injury by downregulating renal cell death and inflammatory responses in mice.
        Int. Immunopharmacol. 2016; 38: 409-419
        • Song Z.
        • Zhang X.
        • Zhang L.
        • Xu F.
        • Tao X.
        • Zhang H.
        • Lin X.
        • Kang L.
        • Xiang Y.
        • Lai X.
        • Zhang Q.
        • Huang K.
        • Dai Y.
        • Yin Y.
        • Cao J.
        Progranulin plays a central role in host defense during sepsis by promoting macrophage recruitment.
        Am. J. Respir. Crit. Care Med. 2016; 194: 1219-1232
        • Talaat R.M.
        • Elmaghraby A.M.
        • Barakat S.S.
        • El-Shahat M.
        Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).
        Clin. Exp. Immunol. 2014; 176: 291-300
        • Culic S.
        • Salamunic I.
        • Konjevoda P.
        • Dajak S.
        • Pavelic J.
        Immune thrombocytopenia: serum cytokine levels in children and adults.
        Med. Sci. Monit. 2013; 19: 797-801
        • Zhong H.
        • Bussel J.
        • Yazdanbakhsh K.
        In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia.
        Br. J. Haematol. 2015; 168: 274-283
        • Zhang G.
        • Zhang P.
        • Liu H.
        • Liu X.
        • Xie S.
        • Wang X.
        • Wu Y.
        • Chang J.
        • Ma L.
        Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model.
        Hematology. 2017; 22: 493-500
        • Frampton G.
        • Invernizzi P.
        • Bernuzzi F.
        • Pae H.Y.
        • Quinn M.
        • Horvat D.
        • Galindo C.
        • Huang L.
        • McMillin M.
        • Cooper B.
        • Rimassa L.
        • DeMorrow S.
        Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism.
        Gut. 2012; 61: 268-277